X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
study-group ghsg (76) 76
index medicus (58) 58
humans (54) 54
oncology (46) 46
chemotherapy (41) 41
hematology (37) 37
disease (36) 36
male (31) 31
female (30) 30
hodgkin disease - therapy (28) 28
adult (26) 26
middle aged (25) 25
adolescent (24) 24
hodgkin disease - pathology (22) 22
radiotherapy (22) 22
lymphomas (21) 21
hodgkin disease - drug therapy (20) 20
hodgkin lymphoma (20) 20
rituximab (19) 19
cancer (18) 18
neoplasm staging (18) 18
aged (17) 17
hodgkin disease - mortality (16) 16
involved-field radiotherapy (16) 16
long-term (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (15) 15
randomized-trial (15) 15
hodgkin disease - diagnosis (14) 14
prognosis (14) 14
treatment outcome (13) 13
hodgkin's disease (12) 12
risk factors (12) 12
child (11) 11
disease-free survival (11) 11
phase-2 trial (11) 11
stem-cell transplantation (11) 11
antineoplastic agents - therapeutic use (10) 10
antineoplastic combined chemotherapy protocols - adverse effects (10) 10
bleomycin (10) 10
brentuximab vedotin (10) 10
high-dose chemotherapy (10) 10
hodgkin disease - radiotherapy (10) 10
hodgkin's lymphoma (10) 10
lymphoma (10) 10
positron-emission-tomography (10) 10
transformation (10) 10
care and treatment (9) 9
elderly-patients (9) 9
european task-force (9) 9
hematology, oncology and palliative medicine (9) 9
open-label (9) 9
recurrence (9) 9
retrospective studies (9) 9
survival rate (9) 9
trial (9) 9
young adult (9) 9
abvd (8) 8
b-cell lymphoma (8) 8
combined modality therapy (8) 8
hodgkin disease - epidemiology (8) 8
radiology, nuclear medicine & medical imaging (8) 8
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
beacopp (7) 7
drug therapy (7) 7
follow-up studies (7) 7
germany (7) 7
ghsg (7) 7
gonadal-function (7) 7
lymphocytes - pathology (7) 7
nlphl (7) 7
prognostic-factors (7) 7
radiation (7) 7
child, preschool (6) 6
children (6) 6
combination chemotherapy (6) 6
extended-field radiotherapy (6) 6
lymphocytes (6) 6
non-inferiority trial (6) 6
older patients (6) 6
radiation therapy (6) 6
abridged index medicus (5) 5
aged 60 years (5) 5
bleomycin - adverse effects (5) 5
bleomycin - therapeutic use (5) 5
bone-marrow-transplantation (5) 5
clinical presentation (5) 5
clinical trials (5) 5
clinical-trials (5) 5
copp-abvd (5) 5
doxorubicin - adverse effects (5) 5
doxorubicin - therapeutic use (5) 5
fertility (5) 5
limited-stage (5) 5
medical research (5) 5
nodular lymphocyte-predominant hodgkin lymphoma (5) 5
pathology (5) 5
patients (5) 5
pediatric-oncology (5) 5
prognostic impact (5) 5
salvage therapy (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BLOOD, ISSN 0006-4971, 12/2017, Volume 130, Issue 26, pp. 2813 - 2814
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 04/2019, Volume 60, Issue 5, pp. 1234 - 1243
Elderly patients with classical Hodgkin lymphoma (cHL) are understudied and poorly defined. The National Cancer Data Base was queried for adults with cHL... 
National Cancer Data Base | elderly | Classical Hodgkin lymphoma | AGED 60 YEARS | BRENTUXIMAB VEDOTIN | BLEOMYCIN | STUDY-GROUP GHSG | RADIATION | THERAPY | OLDER PATIENTS | ONCOLOGY | DISEASE | HD10 | HEMATOLOGY | ABVD CHEMOTHERAPY
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2011, Volume 29, Issue 32, pp. 4234 - 4242
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 2009, Issue 3
Background There are two different international standards for the treatment of early unfavourable and advanced stage Hodgkin lymphoma (HL): chemotherapy with... 
EXTENDED-FIELD RADIOTHERAPY | DOSE-ESCALATION | MEDICINE, GENERAL & INTERNAL | BASE-LINE | FINAL ANALYSIS | INTENSIFIED CHEMOTHERAPY | RANDOMIZED-TRIAL | STUDY-GROUP GHSG | ELDERLY-PATIENTS | CURRENT CLINICAL-TRIALS | DES-LYMPHOMES
Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2019, Volume 184, Issue 1, pp. 82 - 92
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2010, Volume 28, Issue 1, pp. 136 - 141
Purpose The optimal treatment for early-stage, lymphocyte-predominant Hodgkin's lymphoma (LPHL) is not well defined. Treatment has become less aggressive over... 
ONCOLOGY | CLINICAL PRESENTATION | RITUXIMAB | DISEASE | STUDY-GROUP GHSG | RADIOTHERAPY | CHEMOTHERAPY | PHASE-2 TRIAL | Follow-Up Studies | Hodgkin Disease - pathology | Humans | Middle Aged | Child, Preschool | Male | Disease-Free Survival | Lymphocytes - pathology | Hodgkin Disease - therapy | Treatment Failure | Adolescent | Aged, 80 and over | Hodgkin Disease - mortality | Adult | Female | Aged | Neoplasm Staging | Child
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2017, Issue 5, pp. CD007941 - CD007941
Journal Article